-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Acumen Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q2 2024.
- Acumen Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$20.5M, a 76.9% decline year-over-year.
- Acumen Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$64.9M, a 39.5% decline year-over-year.
- Acumen Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$52.4M, a 22.2% decline from 2022.
- Acumen Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$42.9M, a 57.4% increase from 2021.
- Acumen Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$101M, a 1273% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)